HMPV is surging in China. Is the US next?
Advisory Board January 8, 2025
The Future of Cancer Drug Development: Advancements, Challenges, and the Transformative Role of AI
Pharmacy Times January 7, 2025
AI is revolutionizing oncology drug development, enhancing therapeutic identification and reducing approval times, but use of this tool must be carefully implemented to mitigate risks and ensure regulatory compliance.
The landscape of cancer research and drug development is constantly evolving, with groundbreaking advancements shaping the future of oncology treatments. Understanding not only the science but the regulatory concerns, legal challenges, and market climate for this industry is critical.
One of the most significant changes in recent years has been the introduction of artificial intelligence (AI) to drug research and development. This technology is revolutionizing how pharmaceutical companies operate, from initial drug discovery to post-marketing analysis. In the oncology field in particular, AI has the potential to make an important difference...
Today's Sponsors
Today's Sponsor